Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Influenza Immunity: Comparing Nasal FluMist and Injectable Vaxigriptetra Vaccines for Adults

    Not recruiting

    3 1 1
    Investigated Diseases:
    Denmark
  • Study on the Safety and Immune Response of aQIVc HD Vaccine Compared to a Drug Combination for Adults 50 Years and Older at Risk of Flu Complications

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Denmark Estonia Germany
  • A Study of OVX836 Influenza Vaccine Given as Booster or Primary Vaccination in Healthy Adults Who Previously Received OVX836, Influenza Vaccine, or Placebo

    Not recruiting

    2 1 1
    Investigated Diseases:
    Belgium
  • Study on the Best Time for Influenza Vaccine Administration in Adults Aged 60-85 Using Influenza Vaccine and Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    The Netherlands
  • Study Comparing High-Dose vs. Standard-Dose Influenza Vaccine for Preventing Flu in Older Adults

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Denmark
  • Study on the Safety of BIMERVAX and Fluad Tetra for COVID-19 and Influenza in Adults Over 65 Who Are Fully Vaccinated Against COVID-19

    Not recruiting

    2 1 1
    Investigated Diseases:
    Spain
  • Study on the Effectiveness of an MF59-Adjuvanted Influenza Vaccine Compared to a Non-Adjuvanted Vaccine in Adults Aged 65 and Older

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Bulgaria Czechia Finland Italy Lithuania +4
  • Study on the Safety and Immune Response of a New Influenza Vaccine with GSKVX000000034794 in Healthy Younger and Older Adults

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Belgium
  • Study on the Effectiveness and Safety of OVX836 Vaccine for Preventing Influenza in Healthy Adults Aged 18-59

    Not recruiting

    2 1 1
    Investigated Diseases:
    Belgium Finland France Germany
  • Study on the Safety and Effects of Intranasal EV25 in Healthy Adults with and without Influenza Virus Exposure

    Not recruiting

    2 1
    Investigated Diseases:
    Belgium